IVX Insider Trading

Insider Ownership Percentage: 49.07%
Insider Buying (Last 12 Months): A$10,780.88
Insider Selling (Last 12 Months): A$0.00

Invion Insider Trading History Chart

This chart shows the insider buying and selling history at Invion by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Invion Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for IVX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Invion Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/18/2024Robert (Rob) MerrielInsiderExercise2,900,000A$0.01A$14,500.00
5/1/2023Robert (Rob) MerrielInsiderBuy1,540,125A$0.01A$10,780.88
11/17/2022Chiat ChewInsiderIssued22,013,745A$0.01A$220,137.45
9/16/2022Alistair BennallackInsiderExercise3,578,437A$0.01A$46,519.68
9/12/2022Chiat ChewInsiderIssued2,243,898A$0.01A$29,170.67
6/16/2022Robert (Rob) MerrielInsiderIssued1,016,546A$0.01A$9,148.91
12/7/2021Rob MerrielInsiderIssued606,986A$0.02A$10,925.75
10/5/2021Alistair BennallackInsiderExercise2,838,217A$0.01A$39,735.04
9/30/2021Rob MerrielInsiderExercise1,000,000A$0.01A$14,000.00
9/16/2021Alan YamashitaInsiderIssued1,050,528A$0.02A$15,757.92
6/17/2021Rob MerrielInsiderSell1,500,000A$0.02A$22,500.00
6/10/2021Rob MerrielInsiderIssued882,961A$0.02A$14,127.38
6/4/2021Rob MerrielInsiderExercise1,500,000A$0.02A$25,500.00
6/1/2021Alistair BennallackInsiderBuy13,333,333A$0.02A$266,666.66
See Full Table

SEC Filings (Institutional Ownership Changes) for Invion (ASX:IVX)

Invion logo
Invion Limited, a clinical-stage life-sciences company, researches and develops Photosoft technology for the treatment of various cancers, atherosclerosis, and infectious diseases in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, anogenital, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to develop a novel photosensitiser for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. Invion Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.
Read More on Invion

Today's Range

Now: N/A

50 Day Range


52 Week Range

Now: N/A


471,000 shs

Average Volume


Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Invion?

Invion's top insider investors include:
  1. Alistair Bennallack (Insider)
  2. Chiat Chew (Insider)
  3. Chiat Chew (Insider)
  4. Robert (Rob) Merriel (Insider)
Learn More about top insider investors at Invion.